GDF15 and metabolic dysfunction-associated steatohepatitis: Although GDF15 has been related to chronic liver diseases [23,24,25], including some aspects of MASH such as hepatic fibrosis and liver stiffness [25], the potential relationship between circulating levels of GDF15 and key features of MASLD predisposing to atherosclerotic CV disease has not been fully explored.